
Matej Mikulic
Research expert covering health, pharma & medtech

Detailed statistics
Medicare spending on prescription drugs U.S. 1970-2024

Detailed statistics
Medicare Part D plan enrollment in the U.S. 2006-2025

Detailed statistics
Distribution of MA-PD enrollees in the U.S. 2022, by premium

U.S. national health expenditure on prescription drugs 1960-2034
Annual national health expenditure on prescription drugs in the United States from 1960 to 2024, with projections for 2034 (in billion U.S. dollars)

U.S. national health care expenditure in 2015-2024, by category
Distribution of national health care expenditure in the U.S. from 2015 to 2024, by category

Spending on prescription drugs U.S. 2024, by source of funds
Total spending on prescription drugs in the United States in 2024, by source of funds (in billion U.S. dollars)

Out-of-pocket spending on prescription drugs U.S. 1970-2024
Total out-of-pocket (OOP) spending on prescription drugs in the United States from 1970 to 2024 (in billion U.S. dollars)

Medicare spending on prescription drugs U.S. 1970-2024
Medicare spending on prescription drugs in the United States from 1970 to 2024 (in billion U.S. dollars)

Medicaid spending on prescription drugs U.S. 1970-2024
Medicaid spending on prescription drugs in the United States from 1970 to 2024 (in billion U.S. dollars)

Annual change in per capita retail prescription drug spending in the U.S. 2000-2031
Annual change in per capita retail prescription drug spending in the U.S. from 2000 to 2021 and forecast from 2022 to 2031

Retail prescription drug expenditure distribution by payer in the U.S. 2005-2021
Distribution of total national health expenditures on retail prescription drugs in the U.S. in 2005, 2006 and 2021, by payer

Per capita OOP prescribed medicines spending in high-income countries 2022
Estimated out-of-pocket (OOP) spending on prescription drugs per person in selected high-income nations in 2022 (in U.S. dollars)

Prescribed drug spending as a share of total health spending by country in 2022
Share of prescription drug spending as a share of total expenditure on health in selected high-income nations in 2022

Per capita prescribed medicines spending in high-income countries 2022
Estimated spending on prescription drugs per person in selected high-income nations in 2022 (in U.S. dollars)

Medicaid number of prescriptions in the U.S. 2017-2023
Total number of Medicaid prescriptions in the U.S. from FY 2017 to FY 2023 (in millions)

Medicaid gross spending on outpatient prescription drugs 2017-2023
Total Medicaid gross spending on outpatient prescription drugs from FY 2017 to FY 2023 (in billion U.S. dollars)

Medicaid net spending on outpatient prescription drugs 2017-2023
Total Medicaid net spending on outpatient prescription drugs from FY 2017 to FY 2023 (in billion U.S. dollars)

Medicaid net spending per prescription U.S. 2017-2023
Medicaid net spending per prescription in the U.S. from FY 2017 to FY 2023 (in U.S. dollars)

Number of Medicare Part D enrollment in the U.S. 2024, by firm
Total number of Medicare Part D enrollment in the U.S. in 2024, by firm (in million)

Medicare Part D plan enrollment in the U.S. 2006-2025
Total number of beneficiaries enrolled in Medicare Part D plan in the United States from 2006 to 2025

Distribution of MA-PD enrollees in the U.S. 2022, by premium
Distribution of Medicare Advantage prescription drug plan (MA-PD) enrollees in the U.S. in 2022, by premium

Number of Medicare PDP plans available in the U.S. 2024-2025, by state
Number of Medicare Part D stand-alone prescription drug plans (PDPs) in the U.S. in 2024 and 2025, by state

Number of PDPs offered to Medicare Part D patients 2006-2025
Number of stand-alone prescription drug plans (PDPs) offered to Medicare Part D patients from 2006 to 2025

Monthly premium for Medicare Part D PDP and MA-PD in the U.S. from 2006-2024
Average monthly premium of Medicare Part D prescription drug plans (PDPs) and Medicare Advantage drug plan (MA-PD) in the U.S. from 2006 to 2024 (in U.S. dollars)

Average monthly Medicare Part D (prescription drug plan) premium U.S. 2006-2025
Average monthly Medicare Part D (prescription drug plan) premium in the U.S. from 2006 to 2025 (in U.S. dollars)

Premiums for Medicare Part D Rx drug plans 2025
Projected average monthly premiums for the 16 national Medicare Part D stand-alone prescription drug plans (PDP) in the U.S. in 2025

Average reduction in out-of-pocket costs for Part D enrollees in the U.S. in 2025
Estimated average reduction in total out-of-pocket costs for Medicare Part D enrollees in the U.S. in 2025, by state (in U.S. dollars)

Out-of-pocket savings for Part D enrollees reaching new spending limit in 2025
Distribution of out-of-pocket savings for Part D enrollees who will reach the new out-of-pocket spending limit in the U.S. in 2025

MA-PD employer-only group plan enrollment in the U.S. 2006-2025
Total number of beneficiaries enrolled in employer-only group Medicare Advantage drug plan (MA-PD) in the United States from 2006 to 2025

PDP employer-only group plan enrollment in the U.S. 2006-2025
Total number of beneficiaries enrolled in employer-only group prescription drug plan (PDP) in the United States from 2006 to 2025

Large firm employees with specialty drugs coverage in the U.S. in 2025
Share of large firm employees with coverage for specialty prescription drugs in the U.S. in 2025

Coinsurance structures for prescription drug coverage in the U.S. 2025
Distribution of coinsurance structures for covered workers facing coinsurance for prescription drugs in the U.S. in 2025

Cost-sharing formulas for prescription drug benefits among workers U.S. 2025, by plan
Distribution of covered workers facing different cost-sharing formulas for prescription drug benefits in the U.S. in 2025, by plan type

Cost-sharing formulas for prescription drug benefits among workers in U.S. 2017-2025
Distribution of covered workers facing different cost-sharing formulas for prescription drug benefits in the U.S. from 2017 to 2025

Employer satisfaction with PBMs financial performance in selected areas U.S. 2024
Distribution of employers satisfaction with their pharmaceutical benefit managers (PBMs) financial performance in selected areas over the last two plan years in the U.S. as of 2024

Employer satisfaction with PBMs plan design features in the U.S. in 2024
Distribution of employers satisfaction with their pharmaceutical benefit managers (PBMs) plan design features over the last two plan years in the U.S. in 2024

Employer satisfaction with elements of PBMs contracting process U.S. 2024
Distribution of employers satisfaction with key aspects of their pharmaceutical benefit managers (PBMs) contracting process over the last two plan years in the U.S. in 2024

Employer satisfaction with selected features of PBMs in the U.S. in 2024
Distribution of employers satisfaction with selected features of their pharmaceutical benefit managers (PBMs) over the last two plan years in the U.S. in 2024

Support for expanding recipients of Medicare OOP drug cost limits U.S. by party
Support for expanding the 2,000 U.S. dollar annual limit on out-of-pocket (OOP) prescription drug costs beyond people with Medicare in the U.S. in 2024, by party

Policy options Americans favor to keep the prescription drug costs down in 2021
Share of policy options Americans favored to keep the prescription drug costs down as of 2021

Share of Americans who find it difficult to afford Rx medicine 2021, by age group
Share of Americans who say it is difficult to afford the cost of their prescription medicine as of 2021, by age group

Share of Americans who find it difficult to afford Rx drugs 2021 vs. 2023, by income
Share of Americans who say it is difficult to afford the cost of their prescription medicine in 2021 and 2023, by income level
Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.